Skip to main content
Figure 1 | Journal of Biomedical Science

Figure 1

From: Pro-life role for c-Jun N-terminal kinase and p38 mitogen-activated protein kinase at rostral ventrolateral medulla in experimental brain stem death

Figure 1

Activation of JNK and MAP2K4 in RVLM during the pro-life phase of experimental brain stem death. Changes in levels of total or phosphorylated JNK at Thr183 and Tyr185 and changes in levels of total or phosphorylated MAP2K4 at Ser257/Thr261 in folds relative to sham-control (SC), detected in ventrolateral medulla during the pro-life Phase I (MI) or pro-death Phase II (MII) during experimental brain stem death or during comparable time points after treatment with aCSF (AI or AII). Values are presented as mean ± SEM of triplicate analyses on tissue samples pooled from 5-7 animals in each experimental group. *P < 0.05 versus corresponding aCSF group in the post hoc Scheffé multiple-range analysis.

Back to article page